跳至主要内容
临床试验/NCT07742878
NCT07742878招募中不适用

An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury

Rebiscan, Inc.1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2026年7月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10
试验地点
1
主要终点
Device Metrics

研究概览

简要总结

The early prospective study of Traq™ (an investigational binocular ophthalmic neurodiagnostic device) will measure binocular ocular functions (bilateral foveal fixation, foveal binocularity, and fovea-tracked saccadic latency) in normal subjects and those with history of mild-to moderate traumatic brain injury (mTBI).

详细描述

An initial, single-center, prospective, non-masked, non-randomized, parallel-arm clinical study designed to collect Traq™ measurement data from normal subjects (normal arm) and subjects with a history of mild to moderate traumatic brain injury (mTBI) within the last six months (post-TBI arm) to characterize binocular ocular function measurement outcomes across the two study populations.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 12 years or older at the time of enrollment.
  • Able to understand and sign an informed consent form (or with parent/guardian for subjects less than 18 years of age).
  • Willing and able to complete all required study visits and test assessments.
  • Subjects with no history of traumatic brain injury (normal arm).
  • Subjects with a history of mild to moderate traumatic brain injury (mTBI) within the last six months, (post-TBI arm).

排除标准

  • Concurrent participation in another drug or device clinical investigation.
  • Subject with a history of eye disease which could reduce, or limit reflected polarized light from the retina, such as corneal scarring, cataract, glaucoma, degenerative retinal conditions (e.g., age-related macular degeneration, diabetic retinopathy), or other conditions which may decrease device signal reflectance.
  • Subjects who are pregnant, planning to become pregnant, or are breastfeeding.

结局指标

主要结局

Device Metrics

时间窗: Four individual scans through study completion: Day 0, Day 30, Day 60, Day 90.

A composite Traq score will be calculated on a scale of 0.00-to-2.00 at each visit. The score will be a calculated combination of the following, additional outcome measures: * Bilateral foveal fixation * Foveal binocularity * Fovea-tracked saccadic latency

Foveal fixation

时间窗: Four individual scans through study completion: Day 0, Day 30, Day 60, Day 90.

The device will capture each individual eye's ability to fixate as a percentage (from 0.00 to 1.00) of time during the scan. A result will be provided for each individual eye.

Device outputs

时间窗: Four individual scans through study completion: Day 0, Day 30, Day 60, Day 90.

Fovea-tracked saccadic latency will be calculated in milliseconds to measure when fixation is attained and lost throughout the scan.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验